Impact of Tumor-Derived CCL2 on Macrophage Effector Function

Abstract

Monocyte chemoattractant protein-1 (MCP-1, CCL2) is produced by many different types of cells. In the current investigation, the effect of tumor-derived CCL2 on macrophages was evaluated to determine the extent to which this chemokine influenced the innate immune response to cancer. To do this, we used the 4T1 murine mammary carcinoma cell line that constitutively expresses CCL2 and generated 4T1 expressing an antisense CCL2 transcript. The antisense-CCL2-expressing 4T1 produced no detectable CCL2. Macrophages from female BALB/c mice were exposed to supernatants from these tumor cells. The results showed that tumor-derived CCL2 was capable of modulating cytokine gene expression but not protein production in resting, activated, and tumor-associated macrophages. In addition, tumor-derived CCL2 did not affect phagocytic activity, nitric oxide production, or cytolytic activity of the macrophages. Overall, these data suggest that tumor-derived CCL2 does not directly influence macrophage-mediated antitumor activity.

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2005
Source ID
10.1155/jbb.2005.37

Entities

People

  • M. S. Brault
  • R. A. Kurt

Organizations

  • Lafayette College
  • United States Department of Defense

Tags

Fields of Study

  • Medicine

Readers

  • Immunology
  • Immunology and Pathology
  • Oncology (Cancer Research).